<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />



<meta name="date" content="2026-02-13" />

<title>IPL</title>

<script src="rmdlib/header-attrs-2.30/header-attrs.js"></script>
<script src="rmdlib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="rmdlib/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="rmdlib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="rmdlib/navigation-1.1/tabsets.js"></script>
<script src="rmdlib/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="rmdlib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="rmdlib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<meta name="description" content="Indian equities analysis, margin reports, risk, etc..." />
<meta property="og:image" content="https://avatars3.githubusercontent.com/u/21966469?s=400&v=4" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>










<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">StockViz</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-globe"></span>
     
    Macro
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-bnd.html">Fixed Income</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cur.html">Currencies</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cmdy.html">Commodities</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-arrows-v"></span>
     
    52w H&amp;L
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-rocket"></span>
     
    ATH
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-magnet"></span>
     
    Drawdowns
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-train"></span>
     
    Streaks
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-hand-pointer-o"></span>
     
    Indian Indices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-risk.html">Performance Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-IN.html">Index Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-MKT-CAP.html">Classification Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-industry.html">Industry Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-syn.html">Synthetic Indices</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-vol-NIFTY.html">NIFTY Volatility</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-valuations.html">Valuations</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/results-IN.html">Result Dates</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/eq-in/rp-margin.html">Margin Report</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-shopping-bag"></span>
     
    Funds
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports03/mf/rp-IN.html">Indian Mutual Funds</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports03/pms/rp-IN.html">Indian PMS</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-risk.html">US ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-sector.html">US Sector ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-country.html">Country $ ETFs</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-percent"></span>
     
    Fama-French
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-industry.html">Industry</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-factors.html">Factors</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-regression.html">Regressions</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://stockviz.biz">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li>
  <a href="https://stockviz.substack.com">
    <span class="fa fa-envelope-o"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">IPL</h1>
<h3 class="subtitle">Equity Metrics</h3>
<h4 class="date">February 13, 2026</h4>

</div>


<div id="india-pesticides-limited" class="section level1">
<h1>India Pesticides Limited</h1>
<p><a href="/reports01/index/industry/rp-PesticidesAgrochemicals.html">Pesticides &amp; Agrochemicals</a></p>
<div id="annual-returns" class="section level2">
<h2>Annual Returns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.fan.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.annret.png" /></p>
</div>
<div id="cumulative-returns-and-drawdowns" class="section level2">
<h2>Cumulative Returns and Drawdowns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.cumret.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.sma.cumret.png" /></p>
<p><br><br></p>
</div>
<div id="fundamentals" class="section level2">
<h2>Fundamentals</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.eps.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.RevenueFromOperations.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.ebit.png" /></p>
<p><br><br></p>
</div>
<div id="ownership" class="section level2">
<h2>Ownership</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.ownership.png" /></p>
<p><br><br></p>
</div>
<div id="margined" class="section level2">
<h2>Margined</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IPL.mtf.png" /></p>
<p><br><br></p>
<p><br />
</p>
</div>
<div id="ai-summary" class="section level2">
<h2>AI Summary</h2>
<p><em>asof: 2025-12-08 </em></p>
<div id="comprehensive-analysis-of-india-pesticides-limited-ipl" class="section level9">
<p class="heading"><strong>Comprehensive Analysis of India Pesticides Limited (IPL)</strong></p>
<p><em>(Based on Q2 &amp; H1 FY26 Earnings Call Transcript and Press Release ‚Äì November 13, 2025)</em></p>
<hr />
</div>
<div id="i.-company-overview" class="section level6">
<h6><strong>I. Company Overview</strong></h6>
<p><strong>India Pesticides Limited (IPL)</strong> is a specialized agrochemical manufacturer focused on <strong>technical-grade agrochemicals</strong> and <strong>active ingredients (API)</strong>, with growing emphasis on <strong>formulations</strong> and <strong>specialty chemicals</strong>. Established in 1984 and headquartered in Uttar Pradesh, India, the company operates two manufacturing facilities in <strong>Lucknow</strong> and <strong>Sandila (Hardoi)</strong>. Through its subsidiary <strong>Shalvis Specialities (Hamirpur, Himachal Pradesh)</strong>, it is expanding into higher-value specialty molecules.</p>
<p>The company has strong compliance credentials: <strong>ISO 9001:2015, ISO 14001:2015, ISO 45001:2018</strong>, and <strong>ISO 10002:2018</strong> ‚Äî reflecting commitment to quality, safety, environment, and customer satisfaction.</p>
<hr />
</div>
<div id="ii.-financial-summary-q2-h1-fy26-standalone-consolidated" class="section level6">
<h6><strong>II. Financial Summary ‚Äì Q2 &amp; H1 FY26 (Standalone + Consolidated)</strong></h6>
<table>
<thead>
<tr class="header">
<th>Metric</th>
<th>Q2 FY25</th>
<th>Q2 FY26</th>
<th>Growth (YoY)</th>
<th>H1 FY25</th>
<th>H1 FY26</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Revenue (‚Çπ crore)</strong></td>
<td>234</td>
<td>295</td>
<td><strong>+26%</strong></td>
<td>459</td>
<td>579</td>
</tr>
<tr class="even">
<td><strong>EBITDA (‚Çπ crore)</strong></td>
<td>39.2</td>
<td>54.0</td>
<td><strong>+37.6%</strong></td>
<td>70.8</td>
<td>108</td>
</tr>
<tr class="odd">
<td><strong>EBITDA Margin</strong></td>
<td>16.7%</td>
<td>18.3%</td>
<td><strong>+160 bps</strong></td>
<td>15.4%</td>
<td>18.6%</td>
</tr>
<tr class="even">
<td><strong>PAT (‚Çπ Crore)</strong></td>
<td>26.3</td>
<td>32.0</td>
<td><strong>+21.7%</strong></td>
<td>45.7</td>
<td>67.0</td>
</tr>
<tr class="odd">
<td><strong>PAT Margin</strong></td>
<td>11.2%</td>
<td>10.7%</td>
<td>(Flat)</td>
<td>9.9%</td>
<td>11.6%</td>
</tr>
<tr class="even">
<td><strong>ROCE</strong></td>
<td>17.6%</td>
<td>18.8%</td>
<td><strong>+120 bps</strong></td>
<td>-</td>
<td>-</td>
</tr>
<tr class="odd">
<td><strong>Capex (YTD)</strong></td>
<td>-</td>
<td>‚Çπ52 crore (IPL) + ‚Çπ64 crore (Shalvis)</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr class="even">
<td><strong>Working Capital Days</strong></td>
<td>255 (Mar ‚Äò25)</td>
<td>174 (Sep ‚Äò25)</td>
<td><strong>‚Üì81 days</strong></td>
<td>-</td>
<td>-</td>
</tr>
</tbody>
</table>
<blockquote>
<p><strong>Note</strong>: Excluding a one-time insurance claim of ‚Çπ2.29 crore in Q1, underlying margin performance is even stronger.</p>
</blockquote>
<hr />
</div>
<div id="iii.-operational-highlights" class="section level6">
<h6><strong>III. Operational Highlights</strong></h6>
<ul>
<li><strong>Formulation Capacity</strong>: Increased from <strong>6,500 MT to 10,000 MT/year</strong> at Lucknow (~‚Çπ2.8 crore investment).</li>
<li><strong>New Backward Integration Project</strong>: <strong>4,000 MT of 2,6-DEA</strong> at Sandila (~‚Çπ65 crore). Used in herbicides like Pretilachlor &amp; Butachlor.</li>
<li><strong>Shalvis Expansion (Subsidiary)</strong>:
<ul>
<li>Capex of ‚Çπ64 crore FY26; progressing rapidly.</li>
<li>Targeting <strong>~‚Çπ100 crore revenue by FY27</strong>.</li>
<li>Multiple product pipelines under lab/pilot scale; 2 new off-patent molecules expected to launch next year.</li>
</ul></li>
<li><strong>Export Sales</strong>: <strong>Doubled to ‚Çπ140 crore</strong> (from ‚Çπ74 crore in Q2 FY25), now <strong>48% of total revenue</strong>.</li>
<li><strong>Domestic Market</strong>: Down slightly to ‚Çπ150 crore (from ‚Çπ155 crore) due to <strong>heavy monsoon disruptions</strong>.</li>
<li><strong>Revenue Mix</strong>: <strong>66% Technical/API</strong>, <strong>34% Formulations</strong> (bulk formulations for export clients).</li>
<li><strong>Utilization Rate</strong>: Up to <strong>&gt;73%</strong>, driven by export demand recovery and global destocking cycle ending.</li>
</ul>
<hr />
</div>
<div id="iv.-growth-prospects-tailwinds" class="section level6">
<h6><strong>IV. Growth Prospects &amp; Tailwinds</strong></h6>
<div id="strong-export-momentum" class="section level9">
<p class="heading"><strong>1. Strong Export Momentum</strong></p>
<ul>
<li>Export revenue nearly doubled in Q2 (‚Çπ74 Cr ‚Üí ‚Çπ140 Cr).</li>
<li>Management attributes this to <strong>proactive international customer engagement</strong> (Australia, Europe, USA).</li>
<li>Long-term export targeting <strong>40‚Äì45% of revenue</strong>; currently at 48%.</li>
<li>Improved <strong>global demand visibility</strong>, <strong>normalizing inventory levels</strong>.</li>
<li><strong>Government push for exports</strong> and import substitution favorable.</li>
</ul>
</div>
<div id="domestic-market-recovery-in-rabi-season" class="section level9">
<p class="heading"><strong>2. Domestic Market Recovery in Rabi Season</strong></p>
<ul>
<li>Extended monsoon has created <strong>favorable soil moisture</strong>, leading to better Rabi sowing.</li>
<li>Domestic sales, while stagnant in first half, expected to pick up in <strong>H2 FY26</strong>.</li>
<li>Rabi season supports demand for herbicides (like <strong>Pretilachlor</strong>).</li>
</ul>
</div>
<div id="capacity-expansion-backward-integration" class="section level9">
<p class="heading"><strong>3. Capacity Expansion &amp; Backward Integration</strong></p>
<ul>
<li>Formulation capacity up <strong>54%</strong> (6,500 ‚Üí 10,000 MT), enabling export contracts.</li>
<li><strong>Backward integration into 2,6-DEA</strong> to reduce import dependency and improve margins.</li>
<li><strong>PEDA plant expansion to 8,500 MT</strong> nearing completion (delayed due to rains).</li>
<li>Backward integration projects expected to be <strong>margin accretive</strong>.</li>
</ul>
</div>
<div id="shalvis-specialities-engine-of-future-growth" class="section level9">
<p class="heading"><strong>4. Shalvis Specialities: Engine of Future Growth</strong></p>
<ul>
<li>New greenfield site in <strong>Hamirpur</strong>, Himachal Pradesh.</li>
<li>Focused on <strong>specialty chemicals &amp; high-margin niche molecules</strong>.</li>
<li>Targeting <strong>‚Çπ1,000 crore revenue from Shalvis alone over 3‚Äì5 years</strong>.</li>
<li>Already producing small quantities; 2 new molecules expected in FY27.</li>
<li>Revenue from Shalvis expected to reach <strong>‚Çπ100 crore in FY27</strong> ‚Äì supports <strong>INR 1300 cr+ consolidated top-line</strong> estimate.</li>
</ul>
</div>
<div id="healthy-financials-funding-model" class="section level9">
<p class="heading"><strong>5. Healthy Financials &amp; Funding Model</strong></p>
<ul>
<li><strong>Zero debt structure</strong> ‚Äî all expansions funded by <strong>internal accruals</strong>.</li>
<li>Plans to keep <strong>debt-to-equity &lt; 0.1x</strong> ‚Äî conservative financial policy.</li>
<li>Cash balance: <strong>~‚Çπ80 crore</strong>.</li>
<li>Plans for <strong>20‚Äì30 days reduction in working capital cycle</strong> by Mar 2026.</li>
</ul>
</div>
<div id="ambitious-long-term-vision" class="section level9">
<p class="heading"><strong>6. Ambitious Long-Term Vision</strong></p>
<ul>
<li><strong>Revenue Target: ‚Çπ3,000 crore by FY30‚Äì31</strong>, driven by:
<ul>
<li>Integrated manufacturing model.</li>
<li>Backward integration.</li>
<li>Specialty chemistry expansion.</li>
<li>Global footprint expansion.</li>
</ul></li>
<li><strong>Margin Target: 18‚Äì20% EBITDA sustained</strong> via operational efficiency.</li>
</ul>
<hr />
</div>
</div>
<div id="v.-key-challenges-headwinds" class="section level6">
<h6><strong>V. Key Challenges &amp; Headwinds</strong></h6>
<div id="domestic-volatility-due-to-weather" class="section level9">
<p class="heading"><strong>1. Domestic Volatility Due to Weather</strong></p>
<ul>
<li>Heavy monsoon in FY26 caused <strong>delayed pesticide application</strong>, hurting Q2 domestic sales.</li>
<li>Farm access issues reduced demand temporarily.</li>
<li>However, moisture build-up sets up <strong>stronger Rabi demand</strong> in H2.</li>
<li><strong>Seasonality risk</strong> remains ‚Äî domestic demand peaks in Kharif (H1); weaker in Rabi (H2).</li>
</ul>
</div>
<div id="margin-pressure-from-new-capacity" class="section level9">
<p class="heading"><strong>2. Margin Pressure from New Capacity</strong></p>
<ul>
<li>Questions raised on <strong>margin dilution risk</strong> as new plants (Shalvis, PEDA) ramp up.</li>
<li>Management confident that <strong>backward integration and better product mix</strong> will offset depreciation costs.</li>
<li>Still, ramp-up phase may drag margins temporarily.</li>
</ul>
</div>
<div id="high-promoter-shareholding-retail-investor-misalignment" class="section level9">
<p class="heading"><strong>3. High Promoter Shareholding &amp; Retail Investor Misalignment</strong></p>
<ul>
<li>FPO (2021) at ‚Çπ296 ‚Äî stock currently trades <strong>30‚Äì50% lower</strong>.</li>
<li>Retail investors unhappy ‚Äî concerns raised about <strong>lack of buybacks</strong> or investor outreach.</li>
<li>Overhang from <strong>95% promoter sell-side in FPO</strong> affects sentiment.</li>
<li>Company prefers <strong>capex over buybacks</strong>, citing long-term value creation.</li>
</ul>
</div>
<div id="competition-and-pricing-discipline" class="section level9">
<p class="heading"><strong>4. Competition and Pricing Discipline</strong></p>
<ul>
<li>China still a low-cost threat ‚Äî but <strong>anti-dumping duties</strong> on some intermediates helping domestic players.</li>
<li>Management claims <strong>gained market share</strong> from Chinese imports (e.g., <strong>PEDA &gt;90% import substitution</strong>).</li>
<li>Still, need to remain <strong>cost-competitive globally</strong>.</li>
</ul>
</div>
<div id="regulatory-registration-costs" class="section level9">
<p class="heading"><strong>5. Regulatory &amp; Registration Costs</strong></p>
<ul>
<li>FY25 saw <strong>21 new registrations</strong>, costing ~‚Çπ7‚Äì8 lakh per Indian technical registration, ‚Çπ25‚Äì30k for formulations.</li>
<li>Export registrations cost <strong>~‚Çπ25 lakh each</strong> (multi-batch data, compliance).</li>
<li>R&amp;D and registration costs are ongoing pressure points.</li>
</ul>
<hr />
</div>
</div>
<div id="vi.-key-risks" class="section level6">
<h6><strong>VI. Key Risks</strong></h6>
<table>
<colgroup>
<col width="40%" />
<col width="59%" />
</colgroup>
<thead>
<tr class="header">
<th>Risk Type</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Operational Risk</strong></td>
<td>Delays in commissioning new plants (e.g., PEDA) due to weather/construction. Shalvis ramp-up may face execution delays.</td>
</tr>
<tr class="even">
<td><strong>Demand Volatility (Seasonality)</strong></td>
<td>Domestic demand depends on monsoon &amp; sowing cycle ‚Äî susceptible to weather shocks. H2 typically contributes only 45%.</td>
</tr>
<tr class="odd">
<td><strong>Competition from China</strong></td>
<td>Despite anti-dumping relief, China remains low-cost producer. Price undercutting remains a risk unless duties enforce discipline.</td>
</tr>
<tr class="even">
<td><strong>Export Market Shocks</strong></td>
<td>Dependency on Europe, Australia, USA ‚Äî vulnerable to global trade tensions, EPA/EU regulations, currency fluctuation.</td>
</tr>
<tr class="odd">
<td><strong>Margin Sustainability</strong></td>
<td>Current margins at high end of guidance. Maintaining <strong>18‚Äì20% EBITDA</strong> with capex ramp-up is ambitious, though supported by integrated model.</td>
</tr>
<tr class="even">
<td><strong>Execution Risk in Expansion</strong></td>
<td>Ambitious 5-year roadmap ‚Äî requires flawless execution across R&amp;D, Capex, market entry.</td>
</tr>
<tr class="odd">
<td><strong>Valuation Perception Risk</strong></td>
<td>Despite strong fundamentals, <strong>market not recognizing value</strong>; stock underperforming broader indices.</td>
</tr>
</tbody>
</table>
<hr />
</div>
<div id="vii.-summary-investment-thesis" class="section level6">
<h6><strong>VII. Summary &amp; Investment Thesis</strong></h6>
<div id="strengths-bull-case" class="section level9">
<p class="heading">‚úÖ <strong>Strengths (Bull Case)</strong></p>
<ul>
<li><strong>Excellent execution</strong>: On track for ~‚Çπ1,000 crore revenue in FY26.</li>
<li><strong>Strong export growth</strong>: Nearly doubled Y-o-Y ‚Äî signs of <strong>global re-rating</strong>.</li>
<li><strong>Self-reliant, zero-debt model</strong>: Funded growth entirely through internal accruals.</li>
<li><strong>Backward integration &amp; cost efficiency</strong>: Strategic moves to sustain ~18‚Äì20% EBITDA.</li>
<li><strong>High margin technical focus</strong>: 66% of revenue; better ROCE.</li>
<li><strong>Long-term vision</strong>: Clear ‚Çπ3,000 crore roadmap by FY31 with Shalvis as growth engine.</li>
</ul>
</div>
<div id="weaknesses-bear-case" class="section level9">
<p class="heading">‚ö†Ô∏è <strong>Weaknesses (Bear Case)</strong></p>
<ul>
<li><strong>Limited domestic visibility</strong>: Weather-dependent seasonal demand.</li>
<li><strong>Retail investor discontent</strong>: Poor post-FPO performance, lack of buyback.</li>
<li><strong>Execution uncertainty</strong>: Greenfield expansion in Shalvis unproven at scale.</li>
<li><strong>Valuation lag</strong>: Fundamentals outperform price action.</li>
</ul>
<hr />
</div>
</div>
<div id="viii.-outlook-fy26-beyond" class="section level6">
<h6><strong>VIII. Outlook: FY26 &amp; Beyond</strong></h6>
<table>
<colgroup>
<col width="25%" />
<col width="75%" />
</colgroup>
<thead>
<tr class="header">
<th>Element</th>
<th>Guidance/Expectation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>FY26 Revenue</strong></td>
<td>~‚Çπ1,000 crore (on track)</td>
</tr>
<tr class="even">
<td><strong>FY26 EBITDA Margin</strong></td>
<td>18‚Äì20% (on track)</td>
</tr>
<tr class="odd">
<td><strong>FY27 Revenue</strong></td>
<td>~‚Çπ1,200 crore (standalone) + ‚Çπ100 crore (Shalvis) ‚Üí <strong>‚Çπ1,300+ crore</strong></td>
</tr>
<tr class="even">
<td><strong>Pretilachlor Revenues (FY27)</strong></td>
<td>Expected ~‚Çπ250 crore</td>
</tr>
<tr class="odd">
<td><strong>Capex</strong></td>
<td>~‚Çπ116 crore in FY26; incremental, disciplined spending</td>
</tr>
<tr class="even">
<td><strong>Working Capital</strong></td>
<td>Targeting <strong>20‚Äì30 days reduction</strong> by FY26 year-end</td>
</tr>
</tbody>
</table>
<hr />
</div>
<div id="ix.-final-verdict" class="section level6">
<h6><strong>IX. Final Verdict</strong></h6>
<div id="investment-recommendation-accumulate-long-term-focus" class="section level9">
<p class="heading"><strong>‚úÖ Investment Recommendation: Accumulate (Long-Term Focus)</strong></p>
<p><strong>India Pesticides Limited (IPL)</strong> is executing an <strong>ambitious but well-grounded growth strategy</strong> with strong focus on <strong>integrated manufacturing, import substitution, and export-led expansion</strong>. The company‚Äôs shift toward <strong>specialty chemicals via Shalvis</strong>, sustained <strong>high margins</strong>, and <strong>zero-debt model</strong> make it a compelling long-term play on <strong>Make in India and Atmanirbhar Bharat</strong>.</p>
</div>
<div id="bull-case-35-years" class="section level9">
<p class="heading">üîÆ <strong>Bull Case (3‚Äì5 Years)</strong></p>
<ul>
<li>Achieves <strong>‚Çπ3,000 crore revenue by FY31</strong>.</li>
<li>Shalvis becomes a <strong>profitable specialty chemicals hub</strong>.</li>
<li>EBITDA margin holds at <strong>18‚Äì20%</strong>.</li>
<li>Valuation re-rating as earnings visibility improves.</li>
</ul>
</div>
<div id="caveats" class="section level9">
<p class="heading">‚ùó Caveats</p>
<ul>
<li><strong>Only suitable for long-term investors</strong> ‚Äî near-term volatility expected.</li>
<li><strong>Market may underappreciate progress</strong> until export consistency and Shalvis scale are proven.</li>
<li>Retail sentiment may remain weak until governance moves (buyback, more disclosures) are made.</li>
</ul>
<hr />
</div>
</div>
<div id="appendix-key-financial-projections" class="section level6">
<h6><strong>Appendix: Key Financial Projections</strong></h6>
<table>
<thead>
<tr class="header">
<th>Metric</th>
<th>FY26E</th>
<th>FY27E</th>
<th>FY31E</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Revenue (‚Çπ Cr)</strong></td>
<td>1,000</td>
<td>~1,300+</td>
<td>3,000</td>
</tr>
<tr class="even">
<td><strong>EBITDA Margin</strong></td>
<td>18‚Äì20%</td>
<td>18‚Äì20%</td>
<td>18‚Äì20%</td>
</tr>
<tr class="odd">
<td><strong>EBITDA (‚Çπ Cr)</strong></td>
<td>180‚Äì200</td>
<td>234‚Äì260</td>
<td>540‚Äì600</td>
</tr>
<tr class="even">
<td><strong>PAT (‚Çπ Cr)</strong></td>
<td>~110‚Äì120</td>
<td>~140‚Äì150 (assuming ~11% PAT margin)</td>
<td>~300‚Äì330</td>
</tr>
<tr class="odd">
<td><strong>Capex (‚Çπ Cr)</strong></td>
<td>~116</td>
<td>~100‚Äì120</td>
<td>Cumulative over ‚Çπ400 Cr+</td>
</tr>
<tr class="even">
<td><strong>Debt</strong></td>
<td>Near zero</td>
<td>Near zero (D/E &lt; 0.1)</td>
<td>Minimal</td>
</tr>
</tbody>
</table>
<hr />
<p><strong>Conclusion</strong>:<br />
India Pesticides Limited is <strong>not just surviving</strong> the tough agrochemical cycle ‚Äî it‚Äôs <strong>thriving</strong>. With disciplined execution, expanding margins, and a roadmap aligned with national priorities, IPL is positioned to be a <strong>multi-bagger over the next 5 years</strong>, provided it continues to <strong>deliver on promises</strong> and <strong>improves investor outreach</strong>.</p>
<hr />
<p><em>For latest disclosures, visit</em>: <a href="http://www.indiapesticideslimited.com">www.indiapesticideslimited.com</a><br />
<em>For investor queries</em>: <a href="mailto:investor@indiapesticideslimited.com" class="email">investor@indiapesticideslimited.com</a></p>
</div>
</div>
</div>

&nbsp;
&nbsp;
<hr />
<p style="text-align: center;">Copyright &copy; 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.</p>
<p style="text-align: center;"><a href="https://github.com/stockviz/reports/issues">&#x1F41E;</a></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
